Insulin Pens Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Insulin Pens Market Report Overview
The insulin pens market size was $13.75 billion in 2023. The market is expected to grow at a CAGR of more than 5% during 2023-2033. An insulin pen is used to inject insulin for the treatment of diabetes. The pen is composed of an insulin cartridge and a dial to measure the dose of insulin.
Insulin Pens Market Outlook, 2023-2033 ($ Billion)
Buy the Full Report for More Insights into the Insulin Pens Market Forecast
The insulin pens market research report has been created to understand market behavior, which will help identify quantitative market trends in the diabetes care devices therapeutic area. The model discusses in detail the impact of COVID-19 on the insulin pens market for the year 2020 and beyond. The report has extensively covered pipeline products and technologies, which will help in identifying companies with the most robust pipeline. This, in turn, will assist in predictive analysis for designing your in-licensing and out-licensing strategies.
Market Size (2023) | $13.75 billion |
CAGR (2023-2033) | >5% |
Forecast Period | 2024-2033 |
Historical Period | 2015-2023 |
Key Segments | · Disposable Insulin Pens
· Reusable Insulin Pens |
Key Regions | · North America
· Europe · Asia Pacific · South America · Middle East and Africa |
Leading Companies | · Novo Nordisk AS
· Eli Lilly and Co · Sanofi |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Insulin Pens Market Dynamics
Insulin pens are a less painful and user-friendly method for insulin delivery. Therefore, it is widely preferred among patients leading to a significant growth in the insulin pens market. Additionally, competitors invest greatly in R&D to introduce advanced technology in insulin pens. These investments will make insulin delivery as simple and handy as possible.
Insulin Pens Market Segments
The key segments in the insulin pens market are disposable insulin pens and reusable insulin pens. Disposable insulin pens led the insulin pens market in 2023. They allow insulin to be delivered in a more simple, accurate, and convenient way than the vial and syringe method. Disposable insulin pens include an insulin cartridge, a dial to measure dosage, and a disposable needle.
Insulin Pens Market Analysis by Segments, 2023 (%)
Buy the Full Report for More Segment Insights into the Insulin Pens Market
Insulin Pens Market Segmentation by Regions
The key regions in the insulin pens market are North America, Europe, Asia Pacific, South America, and the Middle East and Africa. In 2023, North America dominated the overall insulin pens market and is expected to grow in the forecast period. An increasing number of diabetic population, supportive reimbursement policies, and user-friendly devices will aid the growth of the regional market. The highest revenue is generated in the US because of the high insulin prices.
Insulin Pens Market Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights into the Insulin Pens Market
Insulin Pens Market - Competitive Landscape
A few of the leading companies in the insulin pens market are:
- Novo Nordisk AS
- Eli Lilly and Co
- Sanofi
Eli Lilly and Co. dominated the market in 2023.
Insulin Pens Market Analysis by Companies, 2023 (%)
Buy the Full Report for More Company Insights into the Insulin Pens Market
Segments Covered in the Report
Insulin Pens Segments Outlook (Value, $ Billion, 2015-2033)
- Disposable Insulin Pens
- Reusable Insulin Pens
Insulin Pens Regional Outlook (Value, $ Billion, 2015-2033)
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
Key Inclusions
Currently marketed Insulin Pens and evolving competitive landscape:
- Insightful review of the key industry trends.
- Annualized total Insulin Pens market revenue by segment and market outlooks from 2015-2033.
- Market-level data on units, average selling prices, and market values.
Global, Regional, and Country level market specific insights:
- Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- SWOT analysis for the Insulin Pens market.
- Competitive dynamics insights and trends provided for the Insulin Pens market.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Novo Nordisk AS, Eli Lilly and Co, Sanofi, and others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
This report provides:
- Insightful review of the key industry trends.
- Annualized total Insulin Pens market revenue by segment and market outlooks.
- Market-level data on units, average selling prices, and market values.
- Global, regional, and country-level market-specific insights including qualitative market-specific information with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- SWOT analysis for the Insulin Pens market.
- Competitive dynamics insights and trends provided for the Insulin Pens market.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Reasons to Buy
The model will enable you to:
- Understand the impact of COVID-19 on the Insulin Pens market.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the Insulin Pens market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Insulin Pens market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
- Track device sales in the global and country-specific Insulin Pens market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Frequently asked questions
-
What was the insulin pens market size in 2023?
The insulin pens market size was $13.75 billion in 2023.
-
What will the insulin pens market growth rate be during the forecast period?
The insulin pens market is expected to grow at a CAGR of more than 5% during 2023-2033.
-
Which region dominated the insulin pens market in 2023?
North America dominated the overall insulin pens market in 2023.
-
Which segment led the insulin pens market in 2023?
Disposable insulin pens led the insulin pens market in 2023.
-
Which are the leading companies in the insulin pens market?
A few of the leading companies in the insulin pens market are Novo Nordisk AS, Eli Lilly and Co, and Sanofi, among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.